Merck announces continued commitment to global responsibility
13 September 2012 | By Merck
Report shows progress in the Company's four priority areas...
List view / Grid view
News
GSK to acquire five million shares in Response Genetics for US$1.10 per share in cash
13 September 2012 | By GlaxoSmithKline
GlaxoSmithKline has acquired five million newly issued shares of Response Genetics Inc...
Gerresheimer passes the inspection of all quality inspections
12 September 2012 | By Gerresheimer AG
Gerresheimer Medical Plastic Systems Dongguan Co. is an FDA-inspected medical device...
FDA approves Genzyme’s AUBAGIO®
12 September 2012 | By Sanofi
AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis...
Pfizer and Hisun announce launch of Hisun-Pfizer Pharmaceuticals Co., Ltd.
12 September 2012 | By Pfizer
Pfizer Inc. and Zhejiang Hisun Pharmaceuticals announced the launch of Hisun-Pfizer Pharmaceuticals Co., Ltd...
Asian populations with atrial fibrillation benefit from better stroke prevention with Pradaxa® compared to warfarin
12 September 2012 | By Boehringer Ingelheim
New findings presented at the 2nd Asia Pacific Stroke Conference...
Biogen Idec Foundation awards $1 million to Museum of Science to support stem education in Massachusetts
12 September 2012 | By Biogen Idec
The Biogen Idec Foundation has awarded the Museum of Science, Boston a $1 million grant...
AstraZeneca prices a $2 billion bond issue
12 September 2012 | By AstraZeneca
AstraZeneca PLC has conducted a successful global bond market transaction issuing a total of $2 billion of notes...
bioMérieux launches its VITEK® MS solution for automated, ultra rapid microorganism identification
11 September 2012 | By bioMérieux
VITEK® MS provides microorganism identification in minutes...
Five new grants to advance cancer nursing skills in Central and Eastern Europe
11 September 2012 | By Bristol-Myers Squibb Foundation
Recognizing the increasingly important role nurses play...
WHO grants expansion to the prequalification for Prevenar 13 to include adults 50+ years of age
11 September 2012 | By Pfizer
WHO has granted an expansion to the prequalification for Prevenar 13...
Summit enters technology license agreement with Bristol-Myers Squibb
11 September 2012 | By Peckwater PR
Summit has entered a technology license agreement with Bristol-Myers Squibb Company...
Sanofi Pasteur announces publication in The Lancet of world’s first efficacy results for its dengue vaccine candidate
11 September 2012 | By Sanofi Pasteur
“The complexity of dengue virus infection has hampered vaccine research for decades..."
Merck announces new Phase III data for suvorexant, an investigational insomnia medicine
10 September 2012 | By Merck
Merck remains on target to file a New Drug Application with the FDA in 2012...
Boehringer Ingelheim implements flexible fully disposable up- and downstream manufacturing
10 September 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has developed and now implemented a flexible set-up...
